Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Modulating Movement Intention Via Cortical Stimulation [NA]
A recruiting clinical trial examining whether cortical stimulation can modulate movement intention in individuals with epilepsy and function…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: EPIGUT: EPILEPSY AND GASTROINTESTINAL MICROBIOTA: UNDERSTANDING THERAPY RESPONSE
Clinical trial EPIGUT investigates the relationship between epilepsy and the gastrointestinal microbiota and is currently recruiting, sponso…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Magnetic Resonance-Guided Ultrasound Ablation of the Anterior Nucleus of Thalamus for the Treatment of Drug-resistant Epilepsy. [Phase 1]
A Phase 1 clinical trial to evaluate the safety and effectiveness of MR-guided ultrasound ablation of the anterior nucleus of the thalamus f…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Impact of Epilepsy on the Brainstem Adenosine Pathway and Its Relation With Arousal and Respiratory Reactivity [NA]
This clinical trial update outlines a study on how epilepsy may influence the brainstem adenosine pathway and its links to arousal and respi…
-
FDA approval · 2025-11-25FDA Approved: PERAMPANEL — Original Application (Novadoz Pharmaceuticals LLC)
The FDA approved the original application for a generic form of perampanel from Novadoz Pharmaceuticals LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-11-25FDA Approved: PERAMPANEL — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic version of perampanel (PERAMPANEL) under an original ANDA, expanding access to an adjunc…
-
FDA approval · 2025-11-24FDA Approved: GABAPENTIN — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for gabapentin from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (ANDA211314).
-
FDA approval · 2025-11-21FDA Approved: LEVETIRACETAM — Original Application (Guardian Drug Company)
FDA approval of the original abbreviated new drug application for LEVETIRACETAM (Guardian Drug Company) establishing its generic status.
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Population Pharmacokinetics of Antiepileptic in Pediatrics
This update summarizes a completed study on the population pharmacokinetics of an antiepileptic drug in pediatric patients with epilepsy.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Subiculum Electrical Stimulation for Temporal Lobe Epilepsy With Biliteral Hippocampus Sclerosis(SESTB) [NA]
This Clinical Trial Update covers Subiculum Electrical Stimulation for Temporal Lobe Epilepsy with Bilateral Hippocampus Sclerosis (SESTB); …
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study exploring a neuroleptic-sparing strategy for managing agitated delirium using n…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Evaluating the Impact of Virtual Reality Exposure Therapy on Epilepsy/Seizure-Specific Interictal Anxiety [NA]
A completed clinical trial evaluating the effect of virtual reality exposure therapy on seizure-specific interictal anxiety in epilepsy pati…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Auditory Stimulation Effects on Sleep and Memory in Patients With Epilepsy [NA]
Massachusetts General Hospital is enrolling by invitation in a clinical trial assessing how auditory stimulation during sleep impacts sleep …
-
FDA approval · 2025-11-13FDA Approved: BRIVARACETAM — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved an original application for brivaracetam as a generic drug, with Novadoz Pharmaceuticals LLC listed as the applicant. The appro…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Human Thalamus in Propagation of Temporal Lobe Seizures and Memory Formation [NA]
A Stanford University-sponsored clinical trial is exploring how the human thalamus participates in the propagation of temporal lobe seizures…
-
EMA approval · 2025-11-05EMA Authorised: Pregabalin Viatris Pharma (previously Pregabalin Pfizer) (pregabalin) — Viatris Healthcare Limited
The EMA authorised a pregabalin product under the Viatris Pharma marketing authorisation (formerly Pfizer), for anxiety disorders and epilep…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Readiness Brain Operation Optimization Training (ReBOOT) for Epilepsy Surgery [NA]
A clinical trial update announces the Readiness Brain Operation Optimization Training (ReBOOT) for epilepsy surgery, which is currently recr…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Steps for Epilepsy [NA]
Wake Forest University Health Sciences completed a clinical trial related to epilepsy, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Tools for Anxiety and Depression Screening in Epilepsy [NA]
The clinical trial evaluating tools for screening anxiety and depression in epilepsy has completed, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Epilepsy Adherence in Children and Technology (eACT) [NA]
A completed pediatric epilepsy adherence study evaluating technology-assisted management (eACT) in children; results have been posted.
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: International Post-Stroke Epilepsy Research Repository
A Yale University-sponsored international clinical trial repository focused on post-stroke epilepsy and post-stroke seizures, currently enro…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: Ear-Seizure Detection (EarSD) Study [NA]
The Ear-Seizure Detection (EarSD) clinical trial is studying detection of seizures in people with epilepsy and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective Processing [NA]
A Baylor College of Medicine clinical trial is recruiting to map and modulate the spatiotemporal dynamics of socio-affective processing in t…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy [EARLY_Phase 1]
An early-phase Phase 1 clinical trial led by the University of Minnesota is investigating optimization of deep brain stimulation parameters …
-
FDA approval · 2025-10-23FDA Approved: TOPIRAMATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for Topiramate by Teva Pharmaceuticals under the generic drug pathway.